May 7, 2021
1 min. read

The Latest In Dermatology News: May 7, 2021

Medly

This week, we’re sharing the most recent top stories in dermatology news.

A new study finds psoriasis is associated with an elevated risk of COVID-19. In other news, three new studies show drug efficacy in psoriasis, resected melanoma, and chronic hand eczema.

Read more on these stories below:

Psoriasis Associated With an Increased Risk for COVID-19 in Real-World Study Medscape, April 28, 2021

In the study, some systemic treatments appeared to lower risk in patients, compared with those on topical therapy.

Meet Muneeb Shah, the dermatology resident with 6 million TikTok followers Glossy, April 23, 2021

Dermatology is one of the subjects that has been embraced by the platform with posts from clinicians gaining traction and being widely shared.

Psoriasis Clearance Rates Higher With Bimekizumab vs Secukinumab Medscape, April 28, 2021

At 4 months, 61.7% of those on bimekizumab vs 48.9% on secukinumab, had complete clearance with a PASI score of 100.

Nivolumab Alone Prevails in Resected Melanoma Medpage Today, April 11, 2021

Dual checkpoint blockade with nivolumab (Opdivo) plus ipilimumab (Yervoy) failed to improve outcomes as adjuvant therapy for resected melanoma over nivolumab alone.

Rapid, substantial improvements seen with gusacitinib for chronic hand eczema Healio, May 6, 2021

Gusacitinib produced significant and rapid improvement of severity and pain in patients with moderate to severe chronic hand eczema.

Want to keep updated with Medly? Subscribe to our monthly newsletter!

UTM Source:UTM Campaign:UTM Content:UTM Medium:UTM Term:UTM Device:Landing Page:Company:Last Name:
Join Medly
Partner with Medly
Live Chat